To the Editors:
M ultisystem inflammatory syndrome in children (MIS-C) is a new disease entity seen 3–4 weeks post-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) exposure (symptomatic or asymptomatic) and has predominant cardiac and gastrointestinal system involvement.1 Ventricular dysfunction, coronary dilatation, valvulitis and pericardial effusion have been reported as prominent cardiac findings in MIS-C.2,3 We describe a teenager with MIS-C, who presented with myopericarditis and acute pericardial tamponade, requiring urgent surgical pericardiostomy and drainage.
A 13-year-old girl came with a history of intermittent high-grade fever for 1 week, nausea and vomiting for 3 days and swelling of hands and feet for 2 days. She had a history of SARS-CoV-2 exposure 1 month back but was asymptomatic then. On admission, she was febrile, tachypneic, tachycardiac with a regular pulse that varied in intensity with the respiratory cycle, concerning for pulsus paradoxus, had hypotension, engorged neck veins, facial puffiness and edema over hands and feet. On auscultation, air entry was decreased bilaterally in both lower zones and heart sounds were distant. There was no murmur. Liver was palpable, and the umbilicus was everted. Her reverse transcriptase polymerase chain reaction test for SARS-CoV-2 was negative on admission, and anti–SARS-CoV-2 IgG antibodies were positive. Blood investigations showed increased inflammatory markers (Fig. 1). Chest radiogram showed cardiomegaly and blunted costophrenic angles bilaterally (Fig. 1A).
Echocardiography showed a structurally normal heart but massive pericardial effusion with right atrial and ventricular free wall collapse in diastole, normal biventricular function and bilateral pleural effusion (Fig. 1B and C). In view of both pleural and pericardial effusions, she underwent urgent surgical “wide anterior pericardiectomy” with bilateral intercostal tube drainage, and 650 mL of transudative pericardial fluid was drained. Epicardium and pericardium were intense red colored, and pericardial biopsy confirmed acute inflammation (Fig. 1D and E). She received intravenous immunoglobulin and high-dose intravenous steroids and showed clinical and hemodynamic improvement within 48 hours. She was discharged after 1 week of drain removal, on tapering doses of oral steroids and aspirin. At 1-month follow-up, she was asymptomatic and there was no pericardial collection on echocardiography evaluation.
Pericardial involvement in the acute coronavirus disease 2019 may not always be associated myocardial involvement and can rarely present as tamponade requiring drainage.4 Pericardial involvement in MIS-C has also been known; however, in a recent study, only 20% of children presenting with acute cardiovascular manifestations had associated mild-to-moderate pericardial effusion on echocardiogram, and none had severe effusion.2 MIS-C presenting with pericardial tamponade requiring emergency pericardiocentesis has not been reported. Our case not only shows a rare presentation of MIS-C but also highlights the possibility of surgical intervention in the management of MIS-C. Shock in MIS-C can have multiple reasons, of which, although rare, pericardial tamponade should also be considered.
The authors thank Dr Ashwini Mane-Patil, MD, Pathologist at Aster Aadhar Hospital, Kolhapur, for kindly providing the photomicrographs of pericardial biopsy histopathology slides.
1. Whittaker E, Bamford A, Kenny J, et al.; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324:259–269.
2. Valverde I, Singh Y, Sanchez-de-Toledo J, et al.; AEPC COVID-19 Rapid Response Team*. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation. 2021;143:21–32.
3. Belhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of Global SARS-CoV-2 pandemic. Circulation. 2020;142:429–436.
4. Furqan MM, Verma BR, Cremer PC, et al. Pericardial diseases in COVID19: a contemporary review. Curr Cardiol Rep. 2021;23:90.